Financial Gravity Asset Management’s TherapeuticsMD TXMD Stock Holding History

Financial Gravity Asset Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6	Closed	-$1	–	1658
2022 Q4	$1	Buy	+6	New	+$35	﹤0.01%	1399
2021 Q2	–	Hold	0	–	-$13	–	1021
2021 Q1	–	Sell	-1	Closed	-$78	–	706
2020 Q4	$0	Buy	+1	New	+$68	﹤0.01%	661
2020 Q2	–	Sell	-1	Closed	-$74	–	843
2020 Q1	$74	Hold	1	–	–	﹤0.01%	925
2019 Q4	$2K	Hold	1	–	–	﹤0.01%	1334
2019 Q3	$0	Hold	1	–	–	﹤0.01%	1558
2019 Q2	$0	Hold	1	–	–	﹤0.01%	1667
2019 Q1	$0	Buy	+1	New	+$265	﹤0.01%	1549
2018 Q3	$1K	Buy	6 +3	+100%	+$919	﹤0.01%	1260
2018 Q2	$1K	Sell	3 -1	-25%	-$305	﹤0.01%	1290
2018 Q1	$1K	Buy	+4	New	+$1.12K	﹤0.01%	1274

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Financial Gravity Asset Management's TXMD Position: Q1 2023 in Review

Financial Gravity Asset Management sold out of TherapeuticsMD (TXMD) in Q1 2023, closing a stake of 6 shares — an estimated $1 sold.

Financial Gravity Asset Management first reported a position in TXMD in Q1 2018 and held it in 10 quarters. The position peaked at $2K in Q4 2019. 41 funds tracked by Wall St. Rank hold TXMD as of Q1 2023.

Financial Gravity Asset Management reported no remaining TherapeuticsMD position as of Q1 2023 after selling out during the quarter.
Financial Gravity Asset Management sold 6 TherapeuticsMD shares in Q1 2023, an estimated $1.
Financial Gravity Asset Management first reported a position in TherapeuticsMD in Q1 2018 and held it in 10 quarters.
Financial Gravity Asset Management's TherapeuticsMD position peaked at $2K in Q4 2019.
41 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2023.

Based on Financial Gravity Asset Management's 13F filing for Q1 2023, filed 12 May 2023.